Sequent Scientific Limited
Stock Forecast, Prediction & Price Target
Sequent Scientific Limited Financial Estimates
Sequent Scientific Limited Revenue Estimates
Sequent Scientific Limited EBITDA Estimates
Sequent Scientific Limited Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | |||
Revenue
% change YoY
| ₹13.52B N/A | ₹14.10B 4.29% | ₹13.66B -3.11% | Avg: ₹16.46B Low: ₹16.46B High: ₹16.46B avg. 20.49% | |||
Net Income
% change YoY
| ₹954.42M N/A | ₹409.55M -57.08% | ₹-358.69M -187.58% | Avg: ₹1.89B Low: ₹1.89B High: ₹1.89B avg. 627.77% | |||
EBITDA
% change YoY
| ₹2.11B N/A | ₹1.18B -44.13% | ₹549.8M -53.48% | Avg: ₹1.48B Low: ₹1.48B High: ₹1.48B avg. 169.77% | |||
EPS
% change YoY
| $3.87 N/A | $1.67 -56.84% | -$1.44 -186.22% | Avg: $7.6 Low: $7.6 High: $7.6 avg. 627.77% | |||
Operating Expenses
% change YoY
| ₹4.34B N/A | ₹4.97B 14.51% | ₹5.53B 11.10% | Avg: ₹1.40B Low: ₹1.40B High: ₹1.40B avg. -74.53% | |||
FAQ
What is Sequent Scientific Limited stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 627.77% in 2026-2026.
We have gathered data from N/A analysts. Their low estimate is 1.89B, average is 1.89B and high is 1.89B.
What is Sequent Scientific Limited stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 20.49% in 2026-2026.
We have gathered data from 1 analysts. Their low revenue estimate is ₹16.46B, average is ₹16.46B and high is ₹16.46B.
What is Sequent Scientific Limited stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 627.77% in 2026-2026.
We have gathered data from N/A analysts. Their low earnings per share estimate is $7.6, average is $7.6 and high is ₹7.6.